Antibodies & Hybridomas — page 2 of 52
Antibodies & Hybridomas
Page 2 of 52
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV + CoV-2 Spike | polyclonal | Rabbit | coronavirus sars-cov-2, coronavirus sars-cov | peptide affinity purified | 0.1 mg | n/a |
 LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV-2 Nucleocapsid | A20087F | Mouse | SARS-Cov-2 | purified | 25 µg | n/a |
 BIOLEGEND |
More Info |
| SARS-CoV-2 Nucleocapsid | A20087F | Mouse | SARS-Cov-2 | purified | 100 µg | n/a |
BIOLEGEND |
More Info |
| SARS-CoV-2 RBD | CB6 | Recombinant | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV | Protein A purified | 50 µg | n/a |
 BIOVISION, INC. |
More Info |
| SARS-CoV-2 RBD | CB6 | Recombinant | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV | Protein A purified | 50 µg | n/a |
BIOVISION, INC. |
More Info |
| SARS-CoV-2 NP | 11D5 | Mouse | human | purified | 50 µg | n/a |
BIOVISION, INC. |
More Info |
| SARS-CoV-2 NP | 4G1 | Mouse | n/a | purified | 50 µg | n/a |
BIOVISION, INC. |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein Chimeric | D005 | Chimeric | SARS-CoV-2, SARS-CoV spike RBD, SARS-CoV spike S1, SARs-CoV-2 spike S1, SARS-CoV-2 spike RBD | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein Chimeric | D005 | Chimeric | SARS-CoV-2, SARS-CoV spike RBD, SARS-CoV spike S1, SARs-CoV-2 spike S1, SARS-CoV-2 spike RBD | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3009 (03-009) | Recombinant Human | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 200 µg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3009 (03-009) | Recombinant Human | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 1 mg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3018 (03-018) | Recombinant Human | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 200 µg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3018 (03-018) | Recombinant Human | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 1 mg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3009 (03-009) | Recombinant Rabbit | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 200 µg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3009 (03-009) | Recombinant Rabbit | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 1 mg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3018 (03-018) | Recombinant Rabbit | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 200 µg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | CR3018 (03-018) | Recombinant Rabbit | coronavirus sars-cov-2, coronavirus sars-cov | Protein A purified | 1 mg | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | polyclonal | Rabbit | coronavirus sars-cov | unconjugated | 100 µl | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV + CoV-2 Nucleoprotein | polyclonal | Rabbit | coronavirus sars-cov | unconjugated | 50 µl | n/a |
LIFESPAN BIOSCIENCES INC. |
More Info |
| SARS-CoV-2 (human), Neutralizing | n/a | Recombinant | human | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 E | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 0.02 mg;0.1mg | n/a |
 CREATIVE BIOLABS |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
 ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Rabbit | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike | monoclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
 ORIGENE TECHNOLOGIES |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-AbberiorStar 580 conjugate | 200 µl | n/a |
 SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-AbberiorStar 635P conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-AbberiorStar RED conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-Alexa Fluor®647 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-ATTO 488 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-ATTO 542 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-ATTO 565 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-ATTO 647N conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-Sulfo-Cyanine 3 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| S1 SARS-CoV-2 | W25 | Recombinant Camelid | n/a | single domain-Sulfo-Cyanine 5 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
| SARS-CoV-2 & SARS-CoV NP | monoclonal | Mouse | human | Protein A purified | 100 µg | n/a |
BIOVISION, INC. |
More Info |
| SARS-CoV-2 & SARS-CoV NP | monoclonal | Mouse | human | Protein A purified | 100 µg | n/a |
BIOVISION, INC. |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | biotin conjugate | 50 µl|100 µl | n/a |
 ABBEXA |
More Info |